ABSTRACT
We aimed to develop and validate a Loop-mediated Isothermal Amplification (LAMP) assay to Sporothrix brasiliensis. LAMP reaction was developed using six primers designed based on calmodulin gene. In the LAMP reaction, we tested twenty isolates of S. brasiliensis from animals and humans, along with ten tissue samples extracted from the left footpad of mice that had been experimentally infected with S. brasiliensis. In addition, it included DNA samples from various other fungal species for specificity evaluation. All S. brasiliensis isolates yielded positive results in the LAMP, and the limit of DNA detection was 1 ng/µL. All murine samples were positive in the test while DNA from other fungal species were all negative, resulting in 100% of sensitivity and specificity of primers. LAMP diagnosis technique is a promising alternative to sporotrichosis diagnosis, in a simple and cost-effective way. Further studies are warranted to validate this technique using animal model samples obtained from both humans and animals.
Subject(s)
DNA Primers , Molecular Diagnostic Techniques , Nucleic Acid Amplification Techniques , Sensitivity and Specificity , Sporothrix , Sporotrichosis , Sporothrix/genetics , Sporothrix/isolation & purification , Sporothrix/classification , Sporotrichosis/diagnosis , Sporotrichosis/microbiology , Sporotrichosis/veterinary , Animals , Nucleic Acid Amplification Techniques/methods , Molecular Diagnostic Techniques/methods , Mice , Humans , DNA Primers/genetics , Disease Models, Animal , Calmodulin/geneticsABSTRACT
BACKGROUND: Sporotrichosis is a chronic granulomatous infection of the skin and subcutaneous tissue that can affect any organ through lymphatic spread. The prevalence of sporotrichosis infections is increasing and its treatment is challenging as there are no unified and standard diagnostic techniques or antifungal medications. Controlling further spread requires a rapid diagnosis. Assessment of clinical symptoms, histological analysis, serological testing, and pathogen culture are all necessary for the diagnosis of sporotrichosis. However, these procedures are unable to identify the species. The development of safe, reliable, and species-specific diagnostic techniques is essential. OBJECTIVE: To establish and evaluate a new quantitative real-time PCR assay for the rapid diagnosis of sporotrichosis and to identify relevant species. METHODS: Polymorphisms in calmodulin (CAL) gene sequences and the internal transcribed spacer (ITS) were used in a quantitative real-time PCR assay to identify S. globosa, S. schenckii, and non-target species. RESULTS: The quantitative real-time PCR assay had 100% sensitivity and specificity. The limit of detection was 6 fg/µl. Thirty-four clinical specimens were verified to be infected with S. globosa with a 100% positive detection rate. CONCLUSIONS: The quantitative PCR technique developed in this study is a quick, accurate, and targeted method of identifying S. globosa based on polymorphisms in CAL sequences and ITS. It can be used for a prompt clinical diagnosis to identify S. globosa in clinical specimens from patients with sporotrichosis.
Subject(s)
Calmodulin , Real-Time Polymerase Chain Reaction , Sensitivity and Specificity , Sporothrix , Sporotrichosis , Sporotrichosis/diagnosis , Sporotrichosis/microbiology , Sporothrix/genetics , Sporothrix/isolation & purification , Humans , Real-Time Polymerase Chain Reaction/methods , Calmodulin/genetics , Asia , DNA, Fungal/genetics , Molecular Diagnostic Techniques/methods , Rapid Diagnostic TestsABSTRACT
Introduction. Sporotrichosis is a subcutaneous infection caused by dimorphic Sporothrix species embedded in the clinical clade. Fungi have virulence factors, such as biofilm and melanin production, which contribute to their survival and are related to the increase in the number of cases of therapeutic failure, making it necessary to search for new options.Gap statement. Proton pump inhibitors (PPIs) have already been shown to inhibit the growth and melanogenesis of other fungi.Aim. Therefore, this study aimed to evaluate the effect of the PPIs omeprazole (OMP), rabeprazole (RBP), esomeprazole, pantoprazole and lansoprazole on the susceptibility and melanogenesis of Sporothrix species, and their interactions with itraconazole, terbinafine and amphotericin B.Methodology. The antifungal activity of PPIs was evaluated using the microdilution method, and the combination of PPIs with itraconazole, terbinafine and amphotericin B was assessed using the checkerboard method. The assessment of melanogenesis inhibition was assessed using grey scale.Results. The OMP and RBP showed significant MIC results ranging from 32 to 256 µg ml-1 and 32 to 128 µg ml-1, respectively. Biofilms were sensitive, with a significant reduction (P<0.05) in metabolic activity of 52% for OMP and 50% for RBP at a concentration of 512 µg ml-1 and of biomass by 53% for OMP and 51% for RBP at concentrations of 512 µg ml-1. As for the inhibition of melanogenesis, only OMP showed inhibition, with a 54% reduction.Conclusion. It concludes that the PPIs OMP and RBP have antifungal activity in vitro against planktonic cells and biofilms of Sporothrix species and that, in addition, OMP can inhibit the melanization process in Sporothrix species.
Subject(s)
Amphotericin B , Antifungal Agents , Melanogenesis , Proton Pump Inhibitors , Sporothrix , Sporotrichosis , Humans , Amphotericin B/pharmacology , Amphotericin B/therapeutic use , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Biofilms/drug effects , Biofilms/growth & development , Itraconazole/pharmacology , Melanins/biosynthesis , Melanins/metabolism , Melanogenesis/drug effects , Microbial Sensitivity Tests , Proton Pump Inhibitors/pharmacology , Proton Pump Inhibitors/therapeutic use , Sporothrix/drug effects , Sporothrix/metabolism , Sporotrichosis/drug therapy , Sporotrichosis/microbiology , Terbinafine/pharmacologyABSTRACT
BACKGROUND: Terbinafine has been successfully used in the treatment of human sporotrichosis; however, its effectiveness in the treatment of feline sporotrichosis is unknown. Therefore, this study aimed to describe the use of terbinafine in the treatment of feline sporotrichosis. METHODS: A cohort study was conducted in cats with sporotrichosis to assess the effectiveness and safety of terbinafine (30â60 mg/kg/day). Clinical examination and analysis of laboratory parameters were performed monthly until clinical signs resolved or terbinafine treatment was discontinued. RESULTS: Of the 54 cats with sporotrichosis included in the study, 19 were lost during follow-up and five were withdrawn from the study due to switching to treatment with another prescription drug. Of the remaining 30 cats, 10 achieved clinical cure, with a median treatment time of 18.5 weeks. Treatment failed in 18 cases, and two cats died. Twenty-two cats had adverse reactions to terbinafine treatment, and 10 cats showed elevation of serum transaminases. LIMITATION: Loss during follow-up was high, which makes it difficult to draw accurate conclusions regarding clinical outcomes. CONCLUSION: The low rate of clinical cure observed suggests that terbinafine does not represent an effective treatment option for cases of feline sporotrichosis.
Subject(s)
Antifungal Agents , Cat Diseases , Sporotrichosis , Terbinafine , Cats , Animals , Terbinafine/therapeutic use , Cat Diseases/drug therapy , Sporotrichosis/drug therapy , Sporotrichosis/veterinary , Antifungal Agents/therapeutic use , Antifungal Agents/adverse effects , Treatment Outcome , Male , Female , Cohort StudiesABSTRACT
BACKGROUND: Sporotrichosis is the most common subcutaneous mycosis caused by Sporothrix spp. Traditionally, it is transmitted through injuries involving plant debris. However, over the past few decades, there has been an epidemic increase in human cases resulting from contact with infected animals, particularly cats, in various regions of Brazil. In this report, we report a notable increase in both human and animal cases within the Brazilian Amazon state. METHODOLOGY/PRINCIPAL FINDINGS: An ecological study was conducted by analyzing official records of human and animal sporotrichosis diagnosed in the state of Amazon from 2020 to 2023. Data including patient demographics, clinical manifestations, mycological examination results, and species identification through PCR confirmation were evaluated. During this period, a total of 950 human cases and 2,823 animal cases of sporotrichosis were reported at an exponential rate, since no human cases were registered in 2020. The spatial and temporal dispersion of human sporotrichosis followed that of animal cases, moving from downtown areas to the periphery. Contact with infected animals was reported in 77.7% of cases, with cats being the most commonly implicated (73.5%). Only 66.7% of individuals underwent mycological examination. Among the positive cultures for Sporothrix spp., 65.4% were identified as S. brasiliensis. All patients were treated with systemic antifungals. CONCLUSIONS/SIGNIFICANCE: This study highlights a rising incidence of sporotrichosis among animals and humans in the Brazilian Amazon region over the past four years, with S. brasiliensis being the predominant agent. Collaborative efforts involving healthcare professionals, veterinarians, and public health authorities are crucial to implement effective control measures, educate populations at risk, and promote responsible guidance for pet guardians. These measures are essential to mitigate the burden of epidemic sporotrichosis in Brazil.
Subject(s)
Disease Outbreaks , Sporothrix , Sporotrichosis , Zoonoses , Sporotrichosis/epidemiology , Sporotrichosis/microbiology , Sporotrichosis/veterinary , Brazil/epidemiology , Animals , Humans , Zoonoses/epidemiology , Zoonoses/microbiology , Zoonoses/transmission , Cats , Sporothrix/isolation & purification , Sporothrix/genetics , Male , Female , Adult , Public Health , Middle Aged , Adolescent , Young Adult , Aged , ChildSubject(s)
Cat Diseases , Sporothrix , Sporotrichosis , Sporotrichosis/epidemiology , Sporotrichosis/microbiology , Sporotrichosis/veterinary , Sporotrichosis/drug therapy , Brazil/epidemiology , Cats , Humans , Animals , Cat Diseases/microbiology , Cat Diseases/epidemiology , Sporothrix/isolation & purification , Zoonoses/transmission , Zoonoses/microbiology , Zoonoses/epidemiologyABSTRACT
Itraconazole (ITZ) is the most used drug to treat feline sporotrichosis; however, little is known about its pharmacokinetics in cats with this mycosis. The aim of this study was to determine plasma ITZ concentrations in cats with sporotrichosis treated with ITZ as monotherapy or in combination with potassium iodide (KI). Cats diagnosed with sporotrichosis received orally ITZ (100 mg/cat/day) or combination therapy with ITZ (100 mg/cat/day) and KI (2.5-5 mg/kg/day) in the case of worsening or stagnation of the clinical condition. At each monthly visit, blood samples were collected at an interval of 4 h for analysis of trough and peak plasma ITZ concentrations by HPLC. Clinical features and laboratory parameters were evaluated during follow-up. Sixteen cats were included in the study. The median plasma ITZ concentration of all cats was 0.75 µg/mL. The median plasma ITZ concentration was 0.5 µg/mL in cats that received ITZ monotherapy (n = 12) and 1.0 µg/mL in those treated with ITZ + KI (n = 4). The clinical cure rate was 56.3% (n = 9) and the median treatment duration was 8 weeks. Nine cats (56.3%) developed adverse clinical reactions, and hyporexia was the most frequent (n = 8; 88.9%). Serum alanine aminotransferase was elevated in four cats (25%). The median plasma ITZ concentration detected in cats was considered to be therapeutic (>0.5 µg/mL) and was reached after 4 weeks of treatment. Plasma ITZ concentrations were higher in cats that received ITZ + KI compared to those treated only with ITZ, suggesting pharmacokinetic synergism between these drugs.
Itraconazole is the most common therapy for feline sporotrichosis, and combination therapy with potassium iodide is used in nonresponsive cases. Our study showed that all cats achieved a therapeutic plasma concentration of itraconazole, with higher levels in cats treated with the combination therapy.
Subject(s)
Antifungal Agents , Cat Diseases , Itraconazole , Potassium Iodide , Sporotrichosis , Animals , Cats , Sporotrichosis/drug therapy , Sporotrichosis/veterinary , Sporotrichosis/blood , Itraconazole/blood , Itraconazole/pharmacokinetics , Itraconazole/administration & dosage , Itraconazole/therapeutic use , Cat Diseases/drug therapy , Cat Diseases/blood , Cat Diseases/microbiology , Antifungal Agents/pharmacokinetics , Antifungal Agents/blood , Antifungal Agents/therapeutic use , Antifungal Agents/administration & dosage , Male , Potassium Iodide/therapeutic use , Potassium Iodide/administration & dosage , Potassium Iodide/pharmacokinetics , Female , Treatment Outcome , Drug Therapy, Combination , Administration, Oral , Plasma/chemistryABSTRACT
Zoonotic sporotrichosis caused by Sporothrix brasiliensis is an emerging mycosis in Latin America. One of the problems to quickly treat infected animals and break the transmission chain is associated with the time-consuming gold-standard diagnosis method (culture). We aimed to evaluate a species-specific polymerase chain reaction (PCR) for the diagnosis of sporotrichosis caused by S. brasiliensis using non-invasive samples. We performed a retrospective cross-sectional study using samples collected with swabs from humans and cats with clinical suspicion of sporotrichosis. Deoxyribonucleic acid (DNA) was extracted using a commercial kit, and a species-specific PCR for S. brasiliensis detection was performed. One hundred ten samples were included. PCR showed a good concordance with culture (86% of agreement) for human and cat samples (Kappa coefficient = 0.722, and 0.727, respectively). In conclusion, our data shows that this adapted PCR using non-invasive samples can be applied to sporotrichosis diagnosis, being a good alternative mainly in regions with a lack of mycologists to identify the fungus in culture, contributing to the control of this emergent zoonosis.
We aimed to evaluate a molecular method for diagnosing sporotrichosis caused by Sporothrix brasiliensis in humans and cats. We observed that the technique is in good agreement with the classic method and is a good alternative for assisting in the diagnosis and consequent control of this zoonosis.
Subject(s)
Cat Diseases , Polymerase Chain Reaction , Sporothrix , Sporotrichosis , Sporotrichosis/diagnosis , Sporotrichosis/microbiology , Sporotrichosis/veterinary , Cats , Sporothrix/genetics , Sporothrix/isolation & purification , Sporothrix/classification , Humans , Animals , Polymerase Chain Reaction/methods , Cat Diseases/diagnosis , Cat Diseases/microbiology , Retrospective Studies , Cross-Sectional Studies , Zoonoses/diagnosis , Zoonoses/microbiology , DNA, Fungal/genetics , Molecular Diagnostic Techniques/methods , Sensitivity and SpecificityABSTRACT
The research addresses zoonotic sporotrichosis in Brazil, particularly caused by Sporothrix brasiliensis, highlighting its epidemiological severity. Transmission occurs through contact with sick animals, especially felines, and diagnosis in humans is challenging due to the low fungal load in the lesions. The study analyzed data from Information System for Notifiable Diseases (SINAN) and Zoonosis Surveillance Unit (UVZ) from January 2017 to March 2023, carried out in Contagem, Minas Gerais. Geospatial tools and statistical analysis revealed a significant increase in cases, peaking in 2021 for felines and 2022 for humans. The geospatial analysis highlighted areas of higher incidence, suggesting a correlation between human and feline populations. The research contributes to the understanding of sporotrichosis in Contagem, emphasizing the importance of integrated approaches for surveillance and control strategies, aiming to mitigate impacts on the local community.
Subject(s)
Cat Diseases , Sporotrichosis , Zoonoses , Cats , Animals , Sporotrichosis/veterinary , Sporotrichosis/epidemiology , Sporotrichosis/microbiology , Cat Diseases/epidemiology , Cat Diseases/microbiology , Brazil/epidemiology , Zoonoses/epidemiology , Humans , Incidence , Spatio-Temporal Analysis , SporothrixABSTRACT
Sporotrichosis, a mycosis resulting from cutaneous or subcutaneous infection with the dimorphic fungus Sporothrix, has been reported in China, particularly in the northeast region. In this review, we conducted a thorough examination of the recent advancements in sporotrichosis in China, encompassing aspects such as etiology, epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment strategies. Within the Chinese context, fixed cutaneous sporotrichosis represents the prevailing clinical manifestation. Fungal culture stands as the gold standard for diagnosing sporotrichosis, while polymerase chain reaction techniques can enhance both the specificity and sensitivity of diagnosis. Besides conventional systemic antifungal agents, alternative modalities such as Chinese herbal medicines, photodynamic therapy and laser therapy show potential efficacy against sporotrichosis.
Sporotrichosis is a fungal infection on the skin. It is caused by a group of fungi called Sporothrix. Common symptoms are lesions on the skin, inflammatory papules, nodules and ulcers. These fungi live in the natural environment and cause infection by entering the body through a wound in the skin. China has a high prevalence of sporotrichosis, with northeast China the most seriously affected region. This review looks at the state of sporotrichosis in China.
Subject(s)
Antifungal Agents , Sporothrix , Sporotrichosis , Sporotrichosis/epidemiology , Sporotrichosis/microbiology , Sporotrichosis/drug therapy , Sporotrichosis/diagnosis , China/epidemiology , Humans , Sporothrix/isolation & purification , Sporothrix/genetics , Sporothrix/drug effects , Antifungal Agents/therapeutic use , Polymerase Chain Reaction , PhotochemotherapyABSTRACT
Cat-transmitted sporotrichosis is caused by the emerging fungal pathogen Sporothrix brasiliensis and constitutes a significant public health issue that affects people living in resource-poor urban centers in Brazil. The lack of knowledge about transmission dynamics makes it difficult to propose public health policies to contain the advance of sporotrichosis. We describe the recent emergence of 1,176 cases of sporotrichosis in cats (2016 to 2021) in the metropolitan region of Recife, Brazil, leading to significant zoonotic transmission and an overwhelming occurrence of S. brasiliensis as the etiological agent. Most cases were from cats in the cities of Olinda (408/1,176; 34.70%), Jaboatão dos Guararapes (332/1,176; 28.23%), and Recife (237/1,176; 20.15%). Molecular typing using amplified fragment length polymorphism (EcoRI-GA/MseI-AG) revealed low polymorphic information content (PIC = 0.2499) and heterozygosity (H = 0.2928), typical of an outbreak scenario. Dendrogram and multivariate cluster analysis revealed that isolates from Pernambuco are closely related to Rio de Janeiro isolates. We report a substantial occurrence of MAT1-2 idiomorphs in the metropolitan region of Recife (0:60 ratio; χ2 = 60.000, P < 0.0001). The limited population differentiation and genetic diversity of the isolates from Pernambuco suggest a recent introduction, possibly via a founder effect, from the parental population in Rio de Janeiro. Our findings emphasize the critical importance of molecular surveillance of S. brasiliensis for outbreak response. A comprehensive one-health strategy is mandatory to control the spread of cat-transmitted sporotrichosis driven by S. brasiliensis, encompassing sanitary barriers, quick diagnosis, and treatment.
Subject(s)
Cat Diseases , Sporothrix , Sporotrichosis , Sporotrichosis/transmission , Sporotrichosis/microbiology , Sporotrichosis/veterinary , Sporotrichosis/epidemiology , Cats , Brazil/epidemiology , Sporothrix/genetics , Sporothrix/isolation & purification , Sporothrix/classification , Animals , Cat Diseases/microbiology , Cat Diseases/transmission , Cat Diseases/epidemiology , Molecular Typing , Zoonoses/transmission , Zoonoses/microbiology , Amplified Fragment Length Polymorphism Analysis , Communicable Diseases, Emerging/transmission , Communicable Diseases, Emerging/microbiology , Communicable Diseases, Emerging/epidemiology , Genotype , PhylogenyABSTRACT
A 26-year-old woman presented an eyelid lesion, after being scratched by a cat that had a similar skin lesion. It evolved into a cervical lymph node enlargement. With a hypothesis of Parinaud´s oculoglandular syndrome (POS) due to cat scratch disease (CSD), doxycycline was prescribed. After two weeks of treatment without improvement, a biopsy and blood sample were obtained. Itraconazole was prescribed and the skin lesion improved, but not the lymph node enlargement. A Sporothrix schenckii complex was isolated from the skin sample. Also, a specie-specific polymerase chain reaction detected Bartonella henselae DNA in her blood sample. Azithromycin was included to treat the bacterial infection, whereupon the lymph node also receded successfully. Sporotrichosis and CSD are zoonoses that can be transmitted to humans by traumatic inoculation due to scratches or bites from cats. Both can evolve with POS. Patients who present skin lesions and/or POS after being wounded by a cat should be investigated for both diseases.
Subject(s)
Anti-Bacterial Agents , Bartonella henselae , Cat-Scratch Disease , Coinfection , Sporothrix , Sporotrichosis , Female , Bartonella henselae/isolation & purification , Bartonella henselae/genetics , Humans , Adult , Sporothrix/isolation & purification , Sporothrix/genetics , Sporotrichosis/microbiology , Sporotrichosis/drug therapy , Sporotrichosis/diagnosis , Coinfection/microbiology , Animals , Cats , Anti-Bacterial Agents/therapeutic use , Cat-Scratch Disease/microbiology , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/complications , Cat-Scratch Disease/diagnosis , Azithromycin/therapeutic use , Itraconazole/therapeutic use , Doxycycline/therapeutic use , Skin/microbiology , Skin/pathologyABSTRACT
Sporotrichosis is a globally distributed subcutaneous mycosis caused by dimorphic Sporothrix species commonly found in soil, mosses, and decaying plant matter. The lymphocutaneous manifestation, historically associated with occupational activities and sapronotic transmission, has recently been observed to also occur through animal contact, particularly notable in Brazil. We describe a rare case of lymphocutaneous sporotrichosis with simultaneous pulmonary complications resulting from the scratching of a southern three-banded armadillo, Tolypeutes matacus, primarily inhabiting the arid forests of South America's central region. Speciation using multiplex quantitative polymerase chain reaction (qPCR) established the etiological agent as S. schenckii s. str., while amplified fragment length polymorphism (AFLP) analysis unveiled a novel genotype circulating in the Midwest of Brazil. The patient received treatment with itraconazole (200 mg/day) for two months, leading to substantial clinical improvement of cutaneous and pulmonary symptoms. This case highlights the critical role of animal-mediated transmission in sporotrichosis epidemiology, particularly within regions with diverse armadillo species. The unusual epidemiology and genetic characteristics of this case emphasize the need for enhanced awareness and diagnostic vigilance in atypical sporotrichosis presentations.
Subject(s)
Antifungal Agents , Armadillos , Itraconazole , Sporothrix , Sporotrichosis , Animals , Humans , Male , Amplified Fragment Length Polymorphism Analysis , Antifungal Agents/therapeutic use , Armadillos/microbiology , Brazil , Genotype , Itraconazole/therapeutic use , Multiplex Polymerase Chain Reaction , Sporothrix/genetics , Sporothrix/isolation & purification , Sporothrix/classification , Sporotrichosis/microbiology , Sporotrichosis/diagnosis , Sporotrichosis/drug therapy , Sporotrichosis/transmission , Treatment Outcome , Middle AgedSubject(s)
Sporotrichosis , Sweet Syndrome , Humans , Sporotrichosis/pathology , Sweet Syndrome/pathology , Male , Female , Biopsy , Middle AgedABSTRACT
Introduction: Sporotrichosis is a subcutaneous mycosis caused by fungi of the genus Sporothrix sp. Phenotypic and genotypic differences have been associated with their geographic distribution, virulence, or clinical manifestation of sporotrichosis. In the past decade, the interest in identifying species of the Sporothrix sp. has been increasing, due to its epidemiological importance and, in consequence, is important to know how to preserve them for future studies, in culture collection. Aims: The purposes of this study were to analyze the global distribution of environmental isolates and/or causal agents of sporotrichosis identified by polyphasic taxonomy, with mandatory use of molecular identification, and to evaluate the percentages and distribution of isolates stored in culture collections. Methods: A systematic review of articles on animal and human sporotrichosis and/or environmental isolation of the fungus, from 2007 to 2023, was done. Results: Our results demonstrated that, S. globosa, S. schenckii, and S. brasiliensis were the most identified species. With respect to the deposit and maintenance of species, we observed that only 17% of the strains of Sporothrix sp. isolated in the world are preserved in a culture collection. Conclusions: This systematic review confirmed a difficulty in obtaining the frequency of Sporothrix species stored in culture collection and insufficient data on the molecular identification mainly of animal sporotrichosis and isolation of Sporothrix sp. in environmental samples.
Subject(s)
Sporothrix , Sporotrichosis , Sporothrix/classification , Sporothrix/isolation & purification , Sporothrix/genetics , Sporotrichosis/microbiology , Animals , Humans , Environmental Microbiology , Preservation, Biological/methodsABSTRACT
Sporotrichosis is a widespread fungal infection that affects skin and subcutaneous tissues in humans and animals. In cats, it is displayed as nodules, ulcers and lesions on the nasal and respiratory mucosa. Antifungal treatment of cats is crucial but many cases are difficult, thus resulting in discontinue of the treatment, with disastrous consequences for the animal, encouraging contamination of the environment, other animals and people. The effects of responsible ownership education and health education for owners of cats with feline sporotrichosis as well as the interval between veterinary consultations on treatment outcomes for three groups of owners and their pet cats were evaluated in this study. The responsible ownership education and health education strategies consisted in videos in easy and accessible language for people with any level of education and were presented during consultations for two of the three groups included. The time between appointments was two weeks for two of the groups, and four weeks for one of the groups. The median of treatment time for the group without educational activities was 138 days, while for the other two groups it was 77.5 days and 86 days. It was found a significative reduction in the treatment time in the groups exposed to Responsible ownership education videos. There was no contamination of those responsible for home treatment, and the interval between monthly appointments did not impact on cure or death rates compared to the interval between fortnightly appointments. All these results can be applied to feline sporotrichoses treatment protocols increasing the owners treatment adherence and reducing either, the treatment discontinuation and the treatment costs and helps to control zoonotic sporotrichosis. The importance of attractive and comprehensible educational strategies as part of the feline sporotrichosis treatment protocol for the promotion of one health was highlighted.
Subject(s)
Cat Diseases , Health Education , Ownership , Sporotrichosis , Animals , Cats , Cat Diseases/therapy , Cat Diseases/prevention & control , Cat Diseases/microbiology , Sporotrichosis/veterinary , Sporotrichosis/drug therapy , Sporotrichosis/prevention & control , Sporotrichosis/therapy , Humans , Female , Male , Antifungal Agents/therapeutic useABSTRACT
Vertebrate animal models are essential in research; however, efforts need to be made to decrease animal suffering as much as possible. It could be useful to determine humane endpoints that could serve as surrogates for a fatal outcome. We address this issue with respect to infectious diseases. We propose a humane endpoint for studies of Sporothrix brasiliensis infection. BALB/c mice were inoculated subcutaneously in the footpad. To define a humane endpoint, we considered two groups: animals who died during the experiment, and those euthanized at the end of the experiment. The groups were compared for colony-forming units (CFU) in internal organs, clinical condition, and body weight. Thirteen (22%) animals died before the end of the experiment due to the progression of local infection to severe and disseminated sporotrichosis. Analyzing data of the groups, we propose the following future criteria for euthanasia as a humane endpoint: neurological impairment OR necrosis of the footpad OR loss of ≥ 20% body weight AND moderate to severe dehydration. In view of the current global epidemiological impact of zoonotic sporotrichosis caused by S. brasiliensis, our data could facilitate the utility of models used to study the disease, particularly therapy.